Top 5 Quality Stocks To Buy For 2014

A few years ago I wrote about the composition of the 1% -- the group of the richest Americans that has become the target and the face of wealth inequality. Only 14%, I showed, were in financial services. Another 31% were executives. The rest -- the majority -- were engineers, doctors, small-business owners, salesman, teachers, and other professionals that most wouldn't associate with harming the economy.

So why the bad rap?

I asked Joseph Stiglitz, the Nobel Prize-winning economist who has written extensively about income inequality, in his office at Columbia Business School last week. Have a look (transcript follows):

Stiglitz: The 1% is just a metaphor for saying many of those at the top. I think you have to look at what they're actually doing. I don't think anybody begrudges somebody who would have invented the laser, discovered DNA, from becoming wealthy. They've made an enormous contribution to our society. The irony is that the guys who made these discoveries are not in that top group. The people really transformed our knowledge base that have transformed our society, are not those who are in that 1%.

Top 10 Gold Stocks To Invest In 2015: Kohl's Corporation(KSS)

Kohl?s Corporation operates department stores in the United States. The company?s stores offer private and exclusive, as well as national branded apparel, footwear, and accessories for women, men, and children; soft home products, such as sheets and pillows; and housewares primarily to middle-income customers. As of January 29, 2011, it operated 1,089 stores in 49 states. The company also offers on-line shopping on its Web site at Kohls.com. Kohl?s Corporation was founded in 1962 and is headquartered in Menomonee Falls, Wisconsin.

Advisors' Opinion:

• [By Tom Taulli]

  Valuation. JCP is trading at only 0.16 times overall sales — a bargain if you believe in the store’s recovery. This compares to Macy�� (M) and Kohl’s (KSS) at multiples of 0.6.�Something else: JCP still has some heavy-hitters that are long the stock, including George Soros, Richard Perry of Perry Capital and Kyle Bass of Hayman Capital as of the most recent SEC filings.

• [By Ben Levisohn]

  Nope. Target’s shares have gained 0.7% to $56.99, while competitors were mix. Wal-Mart (WMT) has dropped 0.2% to $75.52, while�Macy’s�(M) has ticked up 0.1% to $56.59, and�Kohl’s (KSS) has advanced 0.7% to $52.70.

• [By John Divine]

  Retail companies took a hit today, and shares of Kohl's (NYSE: KSS  ) lost 2% after a streak of cold weather is set to hit business. Most of the cold weather setbacks are happening in the Northeast, and Kohl's has a large portion of its business in the region. With people not venturing outdoors as much when temperatures plummet, shareholders could be in for a nasty surprise come the earnings announcement May 16.�

Top 5 Quality Stocks To Buy For 2014: Adelaide Resources Ltd (ADN)

Adelaide Resources Limited is an Australia-based company engaged in the exploration for gold, copper, uranium, and other economic mineral deposits. As on June 30, 2012, the Company has interests in 22 exploration licenses, covering over 7,800 square kilometers within South Australia, the Northern Territory and Queensland. The Company holds 100% of the majority of the Moonta Project on Yorke Peninsula in South Australia and a program of aircore and diamond drilling was completed in early 2012 to test a number of targets. The Company�� projects include Rover, Eyre Peninsula, Eyre Peninsula Basement, Yalanda Hill JV, Corrobinnie Palaeochannel Project, Cleve, Anabama, Moonta and Glenroy. The Company subsidiaries include Adelaide Exploration Pty Ltd and Peninsula Resources Limited (formerly Eyre Energy Pty Ltd) Advisors' Opinion:

• [By Tom Stoukas]

  Aberdeen Asset Management Plc (ADN), Scotland�� largest money manager, lost 7.9 percent to 368.5 pence as Goldman Sachs Group Inc. downgraded the stock to neutral from buy.

Top 5 Quality Stocks To Buy For 2014: Amicus Therapeutics Inc.(FOLD)

Amicus Therapeutics Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of orally-administered, small molecule drugs for the treatment of various human genetic diseases. Its drugs are known as pharmacological chaperones, which selectively bind to the target protein, enhance the stability of the protein, help it fold into the three-dimensional shape, and allow proper trafficking of the protein, thereby increasing protein activity, enhance cellular function, and reduce cell stress. The company primarily focuses on lysosomal storage disorders and diseases of neurodegeneration. Its products under development include Amigal, which is in phase III for the treatment of Fabry disease; AT2220, which completed phase I study for the treatment of Pompe disease; and Plicera, that has completed phase I study for the treatment of Gaucher disease. The company has license and collaboration agreement with Glaxo Group Limited to develop and commerc ialize Amigal. The company was founded in 2002 and is based in Cranbury, New Jersey.

Advisors' Opinion:

• [By Rick Munarriz]

  5. You've got to know when to FOLD 'em
  Investing in biotech upstarts can be pretty risky, and Amicus Therapeutics (NASDAQ: FOLD  ) investors learned that the hard way this week.

Top 5 Quality Stocks To Buy For 2014: Guggenheim CurrencyShares Japanese Yen Trust (FXY)

Guggenheim CurrencyShares Japanese Yen Trust, formerly CurrencyShares Japanese Yen Trust, is a grantor trust. The Trust issues shares (the Shares) in blocks of 50,000 (a Basket) in exchange for deposits of Japanese Yen and distributes Japanese Yen in connection with the redemption of Baskets. The investment objective of the Trust is for the Shares to reflect the price of Japanese Yen plus accrued interest, if any, less the expenses of the Trust�� operations. The Trust holds Japanese Yen and, from time to time, issues Baskets in exchange for deposits of Japanese Yen and distributes Japanese Yen in connection with redemptions of Baskets. The Sponsor of the Trust is Guggenheim Specialized Products, LLC, a Delaware limited liability company.

The Bank of New York Mellon, a banking corporation with trust powers organized under the laws of the State of New York, serves as the Trustee. The Shares are backed by the assets of the Trust, which does not hold or use derivative products.

Advisors' Opinion:

• [By Matthew McCall]

  The Rydex CurrencyShares Japanese Yen ETF (NYSE: FXY) has since fallen by nearly 30 percent since hitting a high during the fourth quarter of 2011.